1. Home
  2. COUR vs GERN Comparison

COUR vs GERN Comparison

Compare COUR & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$6.08

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.35

Market Cap

900.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COUR
GERN
Founded
2012
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
900.1M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
COUR
GERN
Price
$6.08
$1.35
Analyst Decision
Buy
Buy
Analyst Count
12
7
Target Price
$12.17
$3.00
AVG Volume (30 Days)
3.8M
11.1M
Earning Date
02-05-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$739,774,000.00
$183,403,000.00
Revenue This Year
$10.46
$147.42
Revenue Next Year
$6.16
$36.02
P/E Ratio
N/A
N/A
Revenue Growth
8.09
522.13
52 Week Low
$5.76
$1.04
52 Week High
$13.56
$3.09

Technical Indicators

Market Signals
Indicator
COUR
GERN
Relative Strength Index (RSI) 25.02 50.56
Support Level $5.98 $1.29
Resistance Level $6.37 $1.40
Average True Range (ATR) 0.26 0.08
MACD -0.01 -0.00
Stochastic Oscillator 7.26 38.64

Price Performance

Historical Comparison
COUR
GERN

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: